NCT00142584View on ClinicalTrials.gov

Evaluation of the Long-term Safety and Tolerability of Metoprolol Versus Nebivolol in Patients With Hypertension

PHASE3CompletedINTERVENTIONAL
Enrollment

336

Participants

Timeline

Start Date

August 31, 2005

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2008

Conditions
Hypertension
Interventions
DRUG

Nebivolol (NEB)

Patients randomized to nebivolol will initiate therapy with nebivolol 5 mg once daily for 4 weeks.

DRUG

Metoprolol (MET)

Patients randomized to metoprolol will initiate therapy with 100 mg once daily for 4 weeks.

Trial Locations (1)

26505

Mylan Pharmaceuticals Inc., Morgantown

Sponsors
All Listed Sponsors
lead

Mylan Bertek Pharmaceuticals

INDUSTRY